228 related articles for article (PubMed ID: 37581048)
1. Diagnostic accuracy of glioma pseudoprogression identification with positron emission tomography imaging: a systematic review and meta-analysis.
Ouyang ZQ; Zheng GR; Duan XR; Zhang XR; Ke TF; Bao SS; Yang J; He B; Liao CD
Quant Imaging Med Surg; 2023 Aug; 13(8):4943-4959. PubMed ID: 37581048
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.
Kebir S; Fimmers R; Galldiks N; Schäfer N; Mack F; Schaub C; Stuplich M; Niessen M; Tzaridis T; Simon M; Stoffels G; Langen KJ; Scheffler B; Glas M; Herrlinger U
Clin Cancer Res; 2016 May; 22(9):2190-6. PubMed ID: 26673798
[TBL] [Abstract][Full Text] [Related]
4. Potential for differentiation of glioma recurrence from radionecrosis using integrated
Sogani SK; Jena A; Taneja S; Gambhir A; Mishra AK; D'Souza MM; Verma SM; Hazari PP; Negi P; Jadhav GK
Neurol India; 2017; 65(2):293-301. PubMed ID: 28290392
[TBL] [Abstract][Full Text] [Related]
5. Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI.
Jena A; Taneja S; Gambhir A; Mishra AK; Dʼsouza MM; Verma SM; Hazari PP; Negi P; Jhadav GK; Sogani SK
Clin Nucl Med; 2016 May; 41(5):e228-36. PubMed ID: 26859208
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of PET for Differentiating True Glioma Progression From Post Treatment-Related Changes: A Systematic Review and Meta-Analysis.
Cui M; Zorrilla-Veloz RI; Hu J; Guan B; Ma X
Front Neurol; 2021; 12():671867. PubMed ID: 34093419
[No Abstract] [Full Text] [Related]
7. Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma.
Galldiks N; Stoffels G; Ruge MI; Rapp M; Sabel M; Reifenberger G; Erdem Z; Shah NJ; Fink GR; Coenen HH; Langen KJ
J Nucl Med; 2013 Dec; 54(12):2046-54. PubMed ID: 24159047
[TBL] [Abstract][Full Text] [Related]
8. Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma.
Kebir S; Khurshid Z; Gaertner FC; Essler M; Hattingen E; Fimmers R; Scheffler B; Herrlinger U; Bundschuh RA; Glas M
Oncotarget; 2017 Jan; 8(5):8294-8304. PubMed ID: 28030820
[TBL] [Abstract][Full Text] [Related]
9. Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression.
Müller M; Winz O; Gutsche R; Leijenaar RTH; Kocher M; Lerche C; Filss CP; Stoffels G; Steidl E; Hattingen E; Steinbach JP; Maurer GD; Heinzel A; Galldiks N; Mottaghy FM; Langen KJ; Lohmann P
J Neurooncol; 2022 Sep; 159(3):519-529. PubMed ID: 35852737
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET.
Galldiks N; Dunkl V; Stoffels G; Hutterer M; Rapp M; Sabel M; Reifenberger G; Kebir S; Dorn F; Blau T; Herrlinger U; Hau P; Ruge MI; Kocher M; Goldbrunner R; Fink GR; Drzezga A; Schmidt M; Langen KJ
Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):685-95. PubMed ID: 25411133
[TBL] [Abstract][Full Text] [Related]
11. Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression.
Zhang J; Wang Y; Wang Y; Xiao H; Chen X; Lei Y; Feng Z; Ma X; Ma L
Quant Imaging Med Surg; 2022 Oct; 12(10):4805-4822. PubMed ID: 36185045
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI.
Werner JM; Stoffels G; Lichtenstein T; Borggrefe J; Lohmann P; Ceccon G; Shah NJ; Fink GR; Langen KJ; Kabbasch C; Galldiks N
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1889-1901. PubMed ID: 31203420
[TBL] [Abstract][Full Text] [Related]
13.
Maurer GD; Brucker DP; Stoffels G; Filipski K; Filss CP; Mottaghy FM; Galldiks N; Steinbach JP; Hattingen E; Langen KJ
J Nucl Med; 2020 Apr; 61(4):505-511. PubMed ID: 31519802
[TBL] [Abstract][Full Text] [Related]
14. Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [
Eisazadeh R; Shahbazi-Akbari M; Mirshahvalad SA; Pirich C; Beheshti M
Semin Nucl Med; 2024 Mar; 54(2):293-301. PubMed ID: 38331629
[TBL] [Abstract][Full Text] [Related]
15. Comparison of
Verger A; Filss CP; Lohmann P; Stoffels G; Sabel M; Wittsack HJ; Kops ER; Galldiks N; Fink GR; Shah NJ; Langen KJ
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2257-2265. PubMed ID: 28831534
[TBL] [Abstract][Full Text] [Related]
16. Sequential implementation of DSC-MR perfusion and dynamic [
Steidl E; Langen KJ; Hmeidan SA; Polomac N; Filss CP; Galldiks N; Lohmann P; Keil F; Filipski K; Mottaghy FM; Shah NJ; Steinbach JP; Hattingen E; Maurer GD
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1956-1965. PubMed ID: 33241456
[TBL] [Abstract][Full Text] [Related]
17. 18F-FET-PET imaging in high-grade gliomas and brain metastases: a systematic review and meta-analysis.
Singnurkar A; Poon R; Detsky J
J Neurooncol; 2023 Jan; 161(1):1-12. PubMed ID: 36502457
[TBL] [Abstract][Full Text] [Related]
18. Imaging tests for the detection of osteomyelitis: a systematic review.
Llewellyn A; Jones-Diette J; Kraft J; Holton C; Harden M; Simmonds M
Health Technol Assess; 2019 Oct; 23(61):1-128. PubMed ID: 31670644
[TBL] [Abstract][Full Text] [Related]
19. A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma.
Kebir S; Schmidt T; Weber M; Lazaridis L; Galldiks N; Langen KJ; Kleinschnitz C; Hattingen E; Herrlinger U; Lohmann P; Glas M
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33105661
[TBL] [Abstract][Full Text] [Related]
20. The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence also in Comparison with MRI.
Santo G; Laudicella R; Linguanti F; Nappi AG; Abenavoli E; Vergura V; Rubini G; Sciagrà R; Arnone G; Schillaci O; Minutoli F; Baldari S; Quartuccio N; Bisdas S
Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
